Home > Insider Trading > Filing (0001104659-16-139276)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1638287	Gemphire Therapeutics Inc.	GEMP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
939478	W Kenneth Kousky	43334 Seven Mile Road Suite 1000 Northville MI 48167		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-08-10	95,439	$0.00	95,439	No	4	C	Indirect	Held by BWA Gemphire Investment Group, LLC
Common Stock	Acquisiton	2016-08-10	10,439	$6.71	105,878	No	4	J	Indirect	Held by BWA Gemphire Investment Group, LLC
Common Stock	Acquisiton	2016-08-10	116,891	$6.71	116,891	No	4	C	Indirect	Held by BWA Gemphire Investment Group II, LLC
Common Stock	Acquisiton	2016-08-10	1,000	$10.00	1,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	Held by BWA Gemphire Investment Group, LLC
No	4	J	Indirect	Held by BWA Gemphire Investment Group, LLC
No	4	C	Indirect	Held by BWA Gemphire Investment Group II, LLC
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2016-08-10	95,439	$0.00	95,439	$0.00
Common Stock	8% Convertible Subordinated Promissory Notes	Disposition	2016-08-10	0	$0.00	116,891	$6.71

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

The Series A Convertible Preferred Stock converted into shares of common stock, par value $0.001 per share (the "Common Stock"), of Gemphire Therapeutics Inc. (the "Company") on a one-for-one basis immediately prior to the closing of the Company's initial public offering and had no expiration date.
Mr. Kousky, as the Manager of BWA Gemphire Investment Group, LLC ("BWA"), beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the securities held by BWA except to the extent of his pecuniary interest therein.
Represents shares of Common Stock issued for payment of accrued dividends on the Series A Convertible Preferred Stock.
Mr. Kousky, as the Manager of BWA Gemphire Investment Group II, LLC ("BWA II"), beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the securities held by BWA II except to the extent of his pecuniary interest therein.
The notes were issued in the original principal amount of $746,500. The outstanding principal and $37,367 of accrued interest on the notes automatically converted into shares of Common Stock immediately prior to the closing of the Company's initial public offering.